Meningococcal vaccine evolution

Meningococcal vaccine evolution

Authors

  • Gianni Bona Clinica Pediatrica, Dipartimento di Scienze Mediche, Università degli Studi del Piemonte Orientale “A. Avogadro”, Novara
  • Carla Guidi Clinica Pediatrica, Dipartimento di Scienze Mediche, Università degli Studi del Piemonte Orientale “A. Avogadro”, Novara

DOI:

https://doi.org/10.7175/cmi.v6i2.627

Keywords:

Meningococcal disease, Neisseria meningitidis, Meningococcal vaccines, Meningococcal conjugate vaccines

Abstract

Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available for the prevention of meningococcal B disease. A general overview of the burden of the disease and the strains prevalence in the world with the focus in particular on the Italian situation is provided in this article, together with the vaccinations developed and under evaluation.

Downloads

Published

2012-06-15

Issue

Section

Clinical management
Loading...